Craig Adam R
Director, Executive Chairman · X4 Pharmaceuticals, Inc
Every open-market stock purchase Craig Adam R has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- XFORX4 Pharmaceuticals, Inc
2 purchases totalling $261.9K at an average of $2.88 per share. See all insider buying in XFOR →
Avg price paid$2.88Latest price—Market capUnknown
All reported buys
Follow new qualifying clusters involving Craig Adam R or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Craig Adam R's Form 4 filings on SEC EDGAR (CIK 1339498) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.